Tagamet HB "faster onset" claim vs. Pepcid AC cleared by federal judge.
This article was originally published in The Tan Sheet
Executive Summary
TAGAMET HB "FASTER ONSET" CLAIM CLEARED BY FEDERAL COURT Judge Harold Baer in a May 24 decision. In a preliminary decision in October, the N.Y. Southern District Court judge had enjoined SmithKline Beecham from claiming that "Tagamet HB has a faster onset of action for heartburn" than J&J/Merck's Pepcid AC in terms of acid control ("The Tan Sheet" Oct. 16, 1995, p. 6).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning